Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.
Reads0
Chats0
TLDR
The depth of invasion was studied using the criteria for staging of Clark et al.2 to see if maximal cross-sectional area, thickness, stage of invasion, or a combination of these can be of value in assessing the prognosis of cutaneous melanoma.Abstract:
CuTANEous melanoma is a most unpredictable lesion. The marked variation in prognosis is probably a function of many variables, one of which is the size of the tumor. Though there is a roughly inverse relationship between the diameter of the lesion and survival,5 very small lesions have recurred or metastasized. One possible reason for the lack of reliability of tumor size in estimating prognosis may be that studies to date have considered size in only two diamensions and have neglected tumor volume. Two melanomas can have the same diameter but differ greatly in thickness because of variation in either depth of invasion or degree of protrusion from the surface of the skin or both. A recent study 2 has shown that prognosis correlates well with staging of the depth of invasion, but there have been no studies relating survival to tumor volume. To measure tumor volume it is necessary to know the surface area of the tumor, but in this retrospective study we only know the maximal diameters of the lesions. By measuring the maximal thickness of the lesions we can calculate the maximal crosssectional area, which should be roughly proportional to the volume of the tumor. The depth of invasion was also studied using the criteria for staging of Clark et al.2 to see if maximal cross-sectional area, thickness, stage of invasion, or a combination of these can be of value in assessing the prognosis of cutaneous melanoma. A total of 98 lesions were so studied.read more
Citations
More filters
Journal ArticleDOI
Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study
TL;DR: The specialized programs of research excellence in skin cancer developed a melanocytic tumor progression tissue microarray (TMA) to evaluate candidate biomarkers and evaluated c‐Kit, MITF, MART1, HMB‐45 and bcl‐2.
Journal ArticleDOI
Assessing the Perceived Needs of Patients Attending an Outpatient Melanoma Clinic
TL;DR: The findings suggest that more research is needed to measure patients' needs routinely, to identify patient groups with specific needs, and to develop methods to meet their needs effectively.
Journal ArticleDOI
Spitzoid melanoma in children: clinicopathological study and application of immunohistochemistry as an adjunct diagnostic tool
Sabela Paradela,Eduardo Fonseca,Salvador Pita,Sara M. Kantrow,Viktor N. Goncharuk,Hafeez Diwan,Victor G. Prieto +6 more
TL;DR: The use of the term spitzoid melanoma (SM) is reserved for a rare group of tumors with striking resemblance to Spitz nevus, often developing in children diagnosed in retrospect after the development of metastases.
Journal ArticleDOI
Incidence and reporting of cutaneous melanoma in Queensland.
TL;DR: The main prognostic features are presented and confirm an increased proportion of thin tumours, particularly of the lentigo maligna melanoma type, which should be considered when seeking to explain the reported rising trends.
Journal ArticleDOI
Photodynamic therapy of melanoma by blue-light photoactivation of flavin mononucleotide.
Roman Akasov,N. V. Sholina,N. V. Sholina,D. A. Khochenkov,A. Alova,Petr V. Gorelkin,Alexander Erofeev,Alexander Erofeev,Alla N. Generalova,Evgeny V. Khaydukov,Evgeny V. Khaydukov,Evgeny V. Khaydukov +11 more
TL;DR: Non-toxic flavin mononucleotide (FMN), which is a water-soluble form of riboflavin (vitamin B2) as a promising agent for photodynamic therapy of melanoma is proposed and selective accumulation of FMN in melanoma cells in vivo and in vitro is demonstrated.
References
More filters
Journal ArticleDOI
Some Methods for Strengthening the Common χ 2 Tests
TL;DR: In this article, the authors discuss two kinds of failure to make the best use of x2 tests which I have observed from time to time in reading reports of biological research, and propose a number of methods for strengthening or supplementing the most common uses of the ordinary x2 test.
Journal Article
The Histogenesis and Biologic Behavior of Primary Human Malignant Melanomas of the Skin
TL;DR: Evidence is presented suggesting that superficial spreading melanoma and lentigo maligna melanoma (Hutchinson9s melanotic freckle) show a long period of superficial growth, followed by the relatively rapid appearance of nodules or deeper invasion within the primary lesion.
Journal ArticleDOI
The Detection of Partial Association, I: The 2 × 2 Case
TL;DR: In this article, a criterion for testing null hypotheses of conditional independence of two dichotomous random variables is derived for testing whether the association of the two random variables in the conditional distribution is, in a certain sense, constant.
Journal ArticleDOI
Clinicopathological correlations in a series of 117 malignant melanomas of the skin of adults.
Related Papers (5)
The Histogenesis and Biologic Behavior of Primary Human Malignant Melanomas of the Skin
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
Charles M. Balch,Antonio C. Buzaid,Seng Jaw Soong,Michael B. Atkins,Natale Cascinelli,Daniel G. Coit,Irvin D. Fleming,Jeffrey E. Gershenwald,Alan Houghton,John M. Kirkwood,Kelly M. McMasters,Martin F. Mihm,Donald L. Morton,Douglas S. Reintgen,M. I. Ross,Arthur J. Sober,John A. Thompson,John F. Thompson +17 more
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch,Jeffrey E. Gershenwald,Seng-Jaw Soong,John F. Thompson,Michael B. Atkins,David R. Byrd,Antonio C. Buzaid,Alistair J. Cochran,Daniel G. Coit,Shouluan Ding,Alexander M.M. Eggermont,Keith T. Flaherty,Phyllis A. Gimotty,John M. Kirkwood,Kelly M. McMasters,Martin C. Mihm,Donald L. Morton,Merrick I. Ross,Arthur J. Sober,Vernon K. Sondak +19 more
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
Charles M. Balch,Seng Jaw Soong,Jeffrey E. Gershenwald,John F. Thompson,Douglas S. Reintgen,Natale Cascinelli,Marshall M. Urist,Kelly M. McMasters,M. I. Ross,John M. Kirkwood,Michael B. Atkins,John A. Thompson,Daniel G. Coit,David R. Byrd,Renee A. Desmond,Yuting Zhang,Ping-Yu Liu,Gary H. Lyman,Aberto Morabito +18 more